Effects of vatinoxan in dogs premedicated with medetomidine and butorphanol followed by sevoflurane anaesthesia: a randomized clinical study
Veterinary Anaesthesia and Analgesia, ISSN: 1467-2987, Vol: 49, Issue: 6, Page: 563-571
2022
- 4Citations
- 43Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
To investigate effects of vatinoxan in dogs, when administered as intravenous (IV) premedication with medetomidine and butorphanol before anaesthesia for surgical castration. A randomized, controlled, blinded, clinical trial. A total of 28 client-owned dogs. Dogs were premedicated with medetomidine (0.125 mg m −2 ) and butorphanol (0.2 mg kg −1 ) (group MB; n = 14), or medetomidine (0.25 mg m −2 ), butorphanol (0.2 mg kg −1 ) and vatinoxan (5 mg m −2 ) (group MB-VATI; n = 14). Anaesthesia was induced 15 minutes later with propofol and maintained with sevoflurane in oxygen (targeting 1.3%). Before surgical incision, lidocaine (2 mg kg −1 ) was injected intratesticularly. At the end of the procedure, meloxicam (0.2 mg kg −1 ) was administered IV. The level of sedation, the qualities of induction, intubation and recovery, and Glasgow Composite Pain Scale short form (GCPS-SF) were assessed. Heart rate (HR), respiratory rate ( f R ), mean arterial pressure (MAP), end-tidal concentration of sevoflurane (F e′ Sevo) and carbon dioxide (P e′ CO 2 ) were recorded. Blood samples were collected at 10 and 30 minutes after premedication for plasma medetomidine and butorphanol concentrations. At the beginning of surgery, HR was 61 ± 16 and 93 ± 23 beats minute −1 ( p = 0.001), and MAP was 78 ± 7 and 56 ± 7 mmHg ( p = 0.001) in MB and MB-VATI groups, respectively. No differences were detected in f R, P e′ CO 2, F e′ Sevo, the level of sedation, the qualities of induction, intubation and recovery, or in GCPS-SF. Plasma medetomidine concentrations were higher in group MB-VATI than in MB at 10 minutes ( p = 0.002) and 30 minutes ( p = 0.0001). Plasma butorphanol concentrations were not different between groups. In group MB, HR was significantly lower than in group MB-VATI. Hypotension detected in group MB-VATI during sevoflurane anaesthesia was clinically the most significant difference between groups.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1467298722001295; http://dx.doi.org/10.1016/j.vaa.2022.08.002; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85138767327&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/36115767; https://linkinghub.elsevier.com/retrieve/pii/S1467298722001295; https://dx.doi.org/10.1016/j.vaa.2022.08.002
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know